The attitudes of Turkish physicians in the treatment of fibromyalgia; is Pregabalinophobia the new reality of pain medicine?

Basit Öğe Kaydı
dc.authoridSalbas, Ender/0000-0001-7460-2889
dc.contributor.authorKetenci, Sertac
dc.contributor.authorGolboyu, Birzat Emre
dc.contributor.authorSalbas, Ender
dc.contributor.authorUzuner, Bora
dc.contributor.authorCiftci, Bahadir
dc.date.accessioned2024-11-07T13:34:17Z
dc.date.available2024-11-07T13:34:17Z
dc.date.issued2022
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjectives: This study aims to determine the treatment preferences of physicians interested in fibromyalgia treatment and to investigate their hesitations about prescribing pregabalin. Methods: Our survey study was conducted between February 5 and 20, 2021. The survey forms were sent to the known email addresses and phone numbers of 1569 physical medicine and rehabilitation (PMR), algology, and rheumatology physicians. The replies to the surveys were checked for possible resubmissions. The pooled data were evaluated with the SPSS 22.0 statistical package program. Frequency distributions were calculated and presented as n, %. Results: Four hundred and six PMR, rheumatology, and algology specialists fulfilled the study forms. About 59.0% of physicians stated that they prefer duloxetine as the first-line agent of fibromyalgia syndrome (FMS) treatment. Pregabalin was only 6.0% of the physicians' first choice for FMS. About 35.0% of the participating physicians stated that the PMR department should follow up FMS patients. About 44.3% of the participants noted that they refer FMS patients to other departments which interested in FMS treatment and do not want to follow-up FMS patients. About 81% agreed that pregabalin causes addiction. About 36.7% stated that at least 20% of the patients could abuse pregabalin and 97.8% of physicians stated that they were prejudiced about prescribing pregabalin to prisoners. Approximately two of the three physicians experienced an act of violence in their hospital regarding pregabalin prescribing. Conclusion: These data showed that the Pregabalinophobia should be accepted. This condition is associated with life safety concerns of the physician not only from unreliability of the drug. It seems that the doctors have valid reasons to develop this prejudice.
dc.identifier.doi10.14744/agri.2021.58235
dc.identifier.endpage209
dc.identifier.issn1300-0012
dc.identifier.issue3
dc.identifier.pmid35792696
dc.identifier.scopus2-s2.0-85133618051
dc.identifier.scopusqualityQ3
dc.identifier.startpage200
dc.identifier.trdizinid1127422
dc.identifier.urihttps://doi.org/10.14744/agri.2021.58235
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1127422
dc.identifier.urihttps://hdl.handle.net/11480/15900
dc.identifier.volume34
dc.identifier.wosWOS:000826219700006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKare Publ
dc.relation.ispartofAgri-The Journal of the Turkish Society of Algology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectDrug abuse
dc.subjectfibromyalgia
dc.subjectpregabalin
dc.subjectpregabalinophobia
dc.titleThe attitudes of Turkish physicians in the treatment of fibromyalgia; is Pregabalinophobia the new reality of pain medicine?
dc.title.alternativeTürk hekimlerinin fibromiyalji tedavisindeki tutumları; pregabalinofobi ağrı tedavisinin yeni gerçeği mi?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu